Arginase inhibitor CB-1158 elicits immune-mediated anti-tumor responses as a single agent and enhances the efficacy of other immunotherapies. (December 2016) - Steggerda, S.; Bennett, M.; Chen, J.; Emberley, E.; Gross, M.; Huang, T.; Li, W.; MacKinnon, A.; Makkouk, A.; Marguier, G.; Neou, S.; Pan, A.; et al.